346 related articles for article (PubMed ID: 36267158)
1. Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma.
Liang Y; Su S; Lun Z; Zhong Z; Yu W; He G; Wang Q; Wang J; Huang S
Front Mol Biosci; 2022; 9():1012505. PubMed ID: 36267158
[No Abstract] [Full Text] [Related]
2. Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes.
Wang G; Li J; Zhu L; Zhou Z; Ma Z; Zhang H; Yang Y; Niu Q; Wang X
Discov Oncol; 2023 Aug; 14(1):147. PubMed ID: 37555866
[TBL] [Abstract][Full Text] [Related]
3. A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma.
Gao L; Xue J; Liu X; Cao L; Wang R; Lei L
Aging (Albany NY); 2021 Nov; 13(22):24866-24881. PubMed ID: 34839280
[TBL] [Abstract][Full Text] [Related]
4. SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma.
Huang Z; Chen X; Wang Y; Yuan J; Li J; Hang W; Meng H
Front Immunol; 2024; 15():1372215. PubMed ID: 38655266
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
[TBL] [Abstract][Full Text] [Related]
6. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
Kui XY; Gao Y; Liu XS; Zeng J; Yang JW; Zhou LM; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Oncol; 2022; 12():809847. PubMed ID: 35957868
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive pan-cancer analysis and the regulatory mechanism of AURKA, a gene associated with prognosis of ferroptosis of adrenal cortical carcinoma in the tumor micro-environment.
Lu K; Yuan X; Zhao L; Wang B; Zhang Y
Front Genet; 2022; 13():996180. PubMed ID: 36685952
[No Abstract] [Full Text] [Related]
9. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
[TBL] [Abstract][Full Text] [Related]
10. Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer.
Zhao L; You Z; Bai Z; Xie J
Front Oncol; 2023; 13():1171878. PubMed ID: 37152064
[TBL] [Abstract][Full Text] [Related]
11. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
Pei W; Jiang M; Liu H; Song J; Hu J
Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
[TBL] [Abstract][Full Text] [Related]
12. Integrative Multi-Omics Analysis of Identified Ferroptosis-Marker RPL8 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Liver Cancer.
Fan S; Zhang S; Kong D; Wang H; Shi Y; Wang Z; Zheng H
Comb Chem High Throughput Screen; 2023; 26(7):1298-1310. PubMed ID: 36017842
[TBL] [Abstract][Full Text] [Related]
13. A Novel Oncogenic Role of Disulfidptosis-related Gene SLC7A11 in Anti--tumor Immunotherapy Response to Human Cancers.
Xu B; Liang J; Fu L; Lin J; Wei J
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38303526
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.
Liu Z; Zhao P
J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083
[TBL] [Abstract][Full Text] [Related]
15. Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy.
Cui Z; Liu C; Li H; Wang J; Li G
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38415454
[TBL] [Abstract][Full Text] [Related]
16. Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma.
Wu L; Quan W; Luo Q; Pan Y; Peng D; Zhang G
Front Mol Biosci; 2020; 7():567950. PubMed ID: 33195412
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
Han X; Long W; Liu Y; Xu J
Front Surg; 2022; 9():985034. PubMed ID: 36338652
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma.
Zhang B; Zhao J; Liu B; Shang Y; Chen F; Zhang S; He J; Fan Y; Tan K
Front Mol Biosci; 2022; 9():940575. PubMed ID: 35847985
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
